Smoking During Pregnancy May Rewire Offspring Brains Through the Gut, Mouse Study Finds

Cigarette smoke during pregnancy has long been flagged as a risk factor for ADHD and related neurodevelopmental problems, but researchers have struggled to explain exactly how the damage unfolds. A new mouse study published in Brain, Behavior, & Immunity by Zhang, Qiu, Shi, and colleagues now points to an unexpected accomplice: the gut. The findings are preliminary, but they sketch a plausible chain of events running from intestinal barrier damage through altered gut metabolites and into specific brain circuits, producing hyperactivity and despair-like behavior that persists into adulthood.

Hyperactivity and Anxiety-Like Behavior Persisted Into Adulthood in Exposed Mice

Pregnant C57BL/6 mice were exposed to whole-body cigarette smoke from before mating through birth, simulating moderate to heavy smoking. Their offspring showed a transient dip in early weight gain, then caught up, but the behavioral story was less benign. In open-field tests at both adolescence (postnatal day 45) and adulthood (day 90), PCE offspring covered significantly greater total distances than controls, a reliable marker of hyperactivity in rodent models. They also spent more time hugging the walls of the arena, a sign of heightened anxiety known as thigmotaxis. On the tail suspension test, they stayed immobile longer, a measure researchers associate with despair-like states.

This pattern echoes what earlier animal work on cigarette smoke exposure identified, including hyperactivity linked to altered monoamine levels and brain-derived neurotrophic factor. What it does not reproduce is the full ADHD picture: the team found no deficits in social interaction, and neither attention nor impulsivity was formally assessed. Taken alongside prior prenatal nicotine research showing anxiety and depression risk, these results strengthen the case that in-utero smoke exposure primes offspring for broad affective and motor dysregulation, not a single disorder.

Region-Specific Brain Activation Points to Stress and Motor Circuits

To understand where in the brain these behavioral changes originate, the team used c-Fos immunofluorescence, a standard marker of recent neuronal firing. The results were surprisingly selective. PCE offspring showed elevated c-Fos in two regions: the paraventricular area (PVA), which integrates stress responses, and the basal ganglia (BG), which governs motor control and habit formation. Five other regions checked, including the medial prefrontal cortex, hippocampus, basolateral amygdala, and nucleus accumbens, showed no significant differences.

The PVA also harbored activated microglia: Iba1 staining revealed enlarged cell bodies and simplified branching, a morphology associated with low-grade neuroinflammation. Crucially, this microglial activation was absent in the basal ganglia, suggesting the two affected regions are responding through different mechanisms. The authors propose that gut-derived signals may be reaching these circuits via immune, endocrine, and vagal pathways, though that chain of events remains to be proven.

A Leaky Gut and Scrambled Metabolites Connect the Periphery to the Brain

The gut findings are where this study breaks new ground. PCE offspring showed reduced colonic expression of Claudin-5, a tight junction protein whose loss signals increased intestinal permeability, a so-called leaky gut. That finding rests on a single protein marker without functional permeability assays, which the authors acknowledge as a limitation. Still, it aligns with rodent data showing that prenatal nicotine exposure reshapes maternal gut microbiota and alters short-chain fatty acid profiles, suggesting the gut is a genuine target of in-utero smoke toxicity.

Untargeted fecal metabolomics in adult offspring identified 161 differential metabolites: 85 upregulated and 76 downregulated compared to controls. The most enriched pathways included glycerophospholipid metabolism, phosphatidylinositol signaling, inositol phosphate metabolism, and arachidonic acid metabolism. Glycerophospholipids and arachidonic acid derivatives are bioactive lipid mediators that regulate neuroinflammation and synaptic plasticity, so their persistent dysregulation in adults is biologically plausible as a long-range influence on brain function. The researchers also flagged the retrograde endocannabinoid signaling pathway and the long-term depression pathway among the altered metabolic signatures.

This gut reprogramming likely begins early. The authors suggest that smoke-altered maternal gut colonization shapes the infant microbiome from birth, setting a metabolic trajectory that outlasts direct exposure.

Why the Causality Question Still Looms Large

The study's most important caveat is that everything reported is correlational. Hyperactivity, brain activation, gut barrier damage, and metabolomic shifts all co-occur in PCE offspring, but no experiment yet establishes which causes which, or whether any peripheral finding drives central changes. Establishing direct causal links between prenatal nicotine exposure and neurodevelopmental outcomes has challenged the field for years, partly because human studies carry uncontrolled confounders and animal models capture only parts of the human condition.

The metabolomics data carry their own statistical caveats. The supervised OPLS-DA model had limited predictive power (Q2 = 0.439), and permutation testing did not reach significance (p = 0.09), flagging possible overfitting in a small sample of six animals per group. The c-Fos measurements reflect resting-state baseline activity rather than task-evoked circuit function, which may or may not map cleanly onto the behavioral phenotypes observed.

Fecal Microbiota Transplants and Targeted Metabolites Are the Next Steps

Despite these limitations, the study opens practical doors. The authors highlight fecal microbiota transplantation (FMT) and targeted metabolite interventions as the experiments needed to establish causality. Butyrate, a short-chain fatty acid and histone deacetylase inhibitor, is singled out as a candidate because of its documented roles in taming neuroinflammation and modulating synaptic plasticity. If butyrate or a related metabolite can rescue the behavioral phenotype in PCE offspring, that would offer both a mechanistic confirmation and a potential therapeutic angle.

The public health context gives these questions urgency. While maternal smoking during pregnancy has declined in the United States, dropping from 7.2% to 4.6% between 2016 and 2021, millions of pregnancies are still exposed each year, and rates remain disproportionately high in rural and lower-income communities. Understanding exactly how smoke exposure translates into neurodevelopmental risk, whether through direct toxicity, gut disruption, or both, could eventually inform interventions that go beyond telling women to quit and into repairing the biological damage when quitting is not immediate.

Evidence rating

INVESTIGATIONAL — 75/100

Caveats:

• Mouse study only — findings have not been replicated in humans.
• Results are correlational; the study does not establish that gut metabolic changes cause the observed behavioral or brain alterations.
• Metabolomics sample size was very small (n=6 per group) and the statistical model showed limited predictive power (Q²=0.439; permutation p=0.09), raising overfitting concerns.
• Intestinal barrier disruption was inferred from a single protein (Claudin-5) without direct functional permeability assays.
• Funding was not disclosed by the authors.

Mouse model study using whole-body cigarette smoke exposure from pre-mating through birth. All findings are associative — the correlations between gut metabolic changes, microglial activation, and behavioral outcomes do not establish causation, and the authors explicitly call for future FMT or intervention studies to test directionality. Metabolomic analyses were conducted on a small subsample (n=6 per group) with a supervised model of limited predictive validity, and the study has not been independently replicated.